Delivery Order SPE2DB22D1106-SPE2DB24FDZT4

Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,319.57 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for M-M-R II vaccine vials. The order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through November...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $1,024.76 and a completion date of April 17, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. The IDC enables...
This is a $26,643.76 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of July 19, 2024 and does not utilize a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a global pharmaceutical and medical supply distributor, to provide M-M-R II vaccine vials. The contract has a firm fixed price of $3,435.87 and a period of performance through March 25, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company, to provide M-M-R II vaccine vials. The contract has a ceiling value of $2,904.90 and a period of performance through March 11, 2024. This delivery order is issued under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corporation with DLA, which has a potential value of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,253.08, is for the delivery of M-M-R II vaccine vials. The award has an ultimate completion date of November 19, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The contract has a potential value of $1,024.78 and a completion date of February 20, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is the prime contractor and holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,574.46 and a completion date of September 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This is a $2,543.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II VACCINE VIALS. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. There is no set-aside designation for this...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of M-M-R II vaccine vials, with a ceiling value of $1,024.76 and a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business category. The company also holds...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDZT4
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of 4,563,635,044 vials of the M-M-R II vaccine, with a potential value of $10,247.60. The contract has a completion date of February 13, 2024 and was awarded on February 12, 2024. This delivery order is issued under a larger, single award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 5/13/24, 9:32 AM